track name="ELK1 (@ Epidermis) 50" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 9997 10285 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 216 . 9997 10285 0,220,255
chr1 2585346 2585668 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 199 . 2585346 2585668 0,202,255
chr1 2585355 2585662 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 112 . 2585355 2585662 0,114,255
chr1 2628919 2629269 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 132 . 2628919 2629269 0,134,255
chr1 2629015 2629325 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 284 . 2629015 2629325 0,255,220
chr1 31904568 31904916 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 288 . 31904568 31904916 0,255,216
chr1 31904612 31904946 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 450 . 31904612 31904946 0,255,51
chr1 91852816 91853079 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 247 . 91852816 91853079 0,251,255
chr1 121354028 121354510 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 360 . 121354028 121354510 0,255,142
chr1 121354103 121354502 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 465 . 121354103 121354502 0,255,35
chr1 121357762 121358181 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 698 . 121357762 121358181 201,255,0
chr1 121357799 121358160 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 716 . 121357799 121358160 220,255,0
chr1 121359908 121360174 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 320 . 121359908 121360174 0,255,183
chr1 121426716 121426991 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 238 . 121426716 121426991 0,242,255
chr1 121478659 121479106 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 271 . 121478659 121479106 0,255,233
chr1 121478730 121479081 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 221 . 121478730 121479081 0,225,255
chr1 121484153 121485433 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 121484153 121485433 255,0,0
chr1 121484153 121485450 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 121484153 121485450 255,0,0
chr1 143279655 143280007 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 267 . 143279655 143280007 0,255,237
chr1 228758115 228758363 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 164 . 228758115 228758363 0,167,255
chr1 236260316 236260719 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 649 . 236260316 236260719 151,255,0
chr1 236260369 236260683 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 633 . 236260369 236260683 135,255,0
chr1 248571480 248572060 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 94 . 248571480 248572060 0,95,255
chr1 249240062 249240379 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 330 . 249240062 249240379 0,255,173
chr1 249240119 249240440 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 291 . 249240119 249240440 0,255,213
chr10 42383423 42383716 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 436 . 42383423 42383716 0,255,65
chr10 42383456 42383720 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 368 . 42383456 42383720 0,255,134
chr10 42384351 42384625 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 306 . 42384351 42384625 0,255,197
chr10 42384898 42385679 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 42384898 42385679 255,0,0
chr10 42384903 42385685 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42384903 42385685 255,0,0
chr10 42387018 42387470 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 989 . 42387018 42387470 255,11,0
chr10 42387039 42387516 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 956 . 42387039 42387516 255,44,0
chr10 42391468 42391801 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 588 . 42391468 42391801 89,255,0
chr10 42391486 42391801 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 553 . 42391486 42391801 54,255,0
chr10 42394033 42394576 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 396 . 42394033 42394576 0,255,106
chr10 42395852 42396327 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42395852 42396327 255,0,0
chr10 42395852 42396389 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 879 . 42395852 42396389 255,123,0
chr10 42396725 42396966 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 242 . 42396725 42396966 0,246,255
chr10 42398459 42398903 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 866 . 42398459 42398903 255,136,0
chr10 42398487 42398894 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 786 . 42398487 42398894 255,218,0
chr10 42400167 42400732 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 42400167 42400732 255,0,0
chr10 42400179 42400721 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42400179 42400721 255,0,0
chr10 42408160 42408408 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 265 . 42408160 42408408 0,255,239
chr10 42527896 42528213 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 529 . 42527896 42528213 29,255,0
chr10 42527914 42528176 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 589 . 42527914 42528176 90,255,0
chr10 42529178 42529853 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 42529178 42529853 255,0,0
chr10 42529196 42529765 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42529196 42529765 255,0,0
chr10 42530562 42530836 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 679 . 42530562 42530836 182,255,0
chr10 42530562 42530856 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 518 . 42530562 42530856 18,255,0
chr10 42534462 42534824 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 774 . 42534462 42534824 255,230,0
chr10 42534483 42534811 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 994 . 42534483 42534811 255,6,0
chr10 42539736 42540133 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 473 . 42539736 42540133 0,255,27
chr10 42539782 42540080 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 593 . 42539782 42540080 94,255,0
chr10 42542892 42543133 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 343 . 42542892 42543133 0,255,160
chr10 42543651 42543898 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 325 . 42543651 42543898 0,255,178
chr10 42545880 42546252 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 664 . 42545880 42546252 167,255,0
chr10 42545924 42546215 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 661 . 42545924 42546215 164,255,0
chr10 42596781 42598218 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 42596781 42598218 255,0,0
chr10 42596800 42597285 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42596800 42597285 255,0,0
chr10 42597481 42598223 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 669 . 42597481 42598223 172,255,0
chr10 42599111 42600425 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 42599111 42600425 255,0,0
chr10 42599472 42600413 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 42599472 42600413 255,0,0
chr10 98510145 98510452 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 115 . 98510145 98510452 0,117,255
chr10 130262651 130262892 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 209 . 130262651 130262892 0,213,255
chr10 135490866 135491232 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 242 . 135490866 135491232 0,246,255
chr10 135490959 135491240 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 254 . 135490959 135491240 0,255,250
chr10 135500253 135501134 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 135500253 135501134 255,0,0
chr10 135500371 135501155 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 908 . 135500371 135501155 255,93,0
chr11 585316 585609 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 177 . 585316 585609 0,180,255
chr11 585318 585608 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 181 . 585318 585608 0,184,255
chr11 48817831 48818072 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 173 . 48817831 48818072 0,176,255
chr11 51569666 51570267 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 447 . 51569666 51570267 0,255,54
chr11 51569674 51570268 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 337 . 51569674 51570268 0,255,166
chr11 51579327 51579713 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51579327 51579713 255,0,0
chr11 51579340 51579722 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51579340 51579722 255,0,0
chr11 51580062 51580781 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51580062 51580781 255,0,0
chr11 51580069 51580858 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51580069 51580858 255,0,0
chr11 51582527 51583098 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51582527 51583098 255,0,0
chr11 51582547 51583091 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51582547 51583091 255,0,0
chr11 51586681 51587108 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51586681 51587108 255,0,0
chr11 51586714 51587095 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51586714 51587095 255,0,0
chr11 51588721 51589178 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51588721 51589178 255,0,0
chr11 51588748 51589157 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51588748 51589157 255,0,0
chr11 51590300 51591316 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 51590300 51591316 255,0,0
chr11 51590301 51591302 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 51590301 51591302 255,0,0
chr11 61734831 61735102 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 333 . 61734831 61735102 0,255,170
chr12 95330 95741 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 487 . 95330 95741 0,255,13
chr12 95343 95746 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 525 . 95343 95746 25,255,0
chr12 2364942 2365325 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 391 . 2364942 2365325 0,255,111
chr12 2365001 2365260 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 339 . 2365001 2365260 0,255,164
chr12 132061392 132061844 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 431 . 132061392 132061844 0,255,70
chr12 132061404 132061822 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 345 . 132061404 132061822 0,255,158
chr12 133841441 133841947 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 133841441 133841947 255,0,0
chr12 133841481 133841929 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 133841481 133841929 255,0,0
chr14 50053214 50053535 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 243 . 50053214 50053535 0,247,255
chr14 50053262 50053554 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 316 . 50053262 50053554 0,255,187
chr15 21315619 21316062 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 221 . 21315619 21316062 0,225,255
chr15 21315824 21316128 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 126 . 21315824 21316128 0,128,255
chr16 1075259 1075641 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 225 . 1075259 1075641 0,229,255
chr16 1075302 1075552 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 153 . 1075302 1075552 0,156,255
chr16 33238940 33239528 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 127 . 33238940 33239528 0,129,255
chr16 33293849 33294360 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 381 . 33293849 33294360 0,255,121
chr16 33293924 33294419 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 307 . 33293924 33294419 0,255,196
chr16 33974220 33974719 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 133 . 33974220 33974719 0,135,255
chr16 33974324 33974756 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 187 . 33974324 33974756 0,190,255
chr16 33975038 33975706 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 265 . 33975038 33975706 0,255,239
chr16 33975070 33975685 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 320 . 33975070 33975685 0,255,183
chr16 34022591 34022868 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 430 . 34022591 34022868 0,255,71
chr16 46386534 46387101 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 266 . 46386534 46387101 0,255,238
chr16 46386842 46387186 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 225 . 46386842 46387186 0,229,255
chr16 46389603 46389844 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 280 . 46389603 46389844 0,255,224
chr16 46389611 46389971 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 208 . 46389611 46389971 0,212,255
chr16 46391024 46391659 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 389 . 46391024 46391659 0,255,113
chr16 46391048 46392270 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 393 . 46391048 46392270 0,255,109
chr16 46391879 46392280 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 378 . 46391879 46392280 0,255,124
chr16 46393969 46394214 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 225 . 46393969 46394214 0,229,255
chr16 46394570 46394866 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 180 . 46394570 46394866 0,183,255
chr16 46394587 46395483 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 317 . 46394587 46395483 0,255,186
chr16 46395127 46395443 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 347 . 46395127 46395443 0,255,156
chr16 46401829 46402172 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 253 . 46401829 46402172 0,255,251
chr16 46401851 46402168 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 287 . 46401851 46402168 0,255,217
chr16 46404340 46404684 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 129 . 46404340 46404684 0,131,255
chr16 46404926 46405758 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 377 . 46404926 46405758 0,255,125
chr16 46404973 46405577 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 334 . 46404973 46405577 0,255,169
chr16 46406006 46407070 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 465 . 46406006 46407070 0,255,35
chr16 46406106 46407052 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 454 . 46406106 46407052 0,255,46
chr16 46408246 46408572 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 370 . 46408246 46408572 0,255,132
chr16 46408247 46408579 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 414 . 46408247 46408579 0,255,87
chr16 46412881 46413416 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 624 . 46412881 46413416 126,255,0
chr16 46412894 46413417 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 645 . 46412894 46413417 147,255,0
chr16 46416842 46417366 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 286 . 46416842 46417366 0,255,218
chr16 46416945 46417428 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 165 . 46416945 46417428 0,168,255
chr16 46420271 46420529 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 427 . 46420271 46420529 0,255,74
chr16 46421627 46422090 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 363 . 46421627 46422090 0,255,139
chr16 46421687 46421953 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 289 . 46421687 46421953 0,255,215
chr16 46423723 46424283 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 294 . 46423723 46424283 0,255,210
chr16 46423739 46424309 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 210 . 46423739 46424309 0,214,255
chr16 46424512 46424812 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 211 . 46424512 46424812 0,215,255
chr16 46427002 46427504 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 137 . 46427002 46427504 0,139,255
chr16 46427084 46427566 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 125 . 46427084 46427566 0,127,255
chr16 46432439 46433358 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 46432439 46433358 255,0,0
chr16 46432462 46433311 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 46432462 46433311 255,0,0
chr16 46433997 46434335 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 299 . 46433997 46434335 0,255,205
chr16 46435146 46435523 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 565 . 46435146 46435523 66,255,0
chr16 46435221 46435512 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 531 . 46435221 46435512 31,255,0
chr16 90183209 90183672 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 156 . 90183209 90183672 0,159,255
chr17 966713 967066 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 100 . 966713 967066 0,102,255
chr17 22244779 22245022 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 311 . 22244779 22245022 0,255,192
chr17 22245572 22245975 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 487 . 22245572 22245975 0,255,13
chr17 22245578 22245977 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 633 . 22245578 22245977 135,255,0
chr17 22247827 22248183 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 708 . 22247827 22248183 212,255,0
chr17 22247855 22248277 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 574 . 22247855 22248277 75,255,0
chr17 22249443 22249763 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 191 . 22249443 22249763 0,194,255
chr17 22249464 22249762 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 184 . 22249464 22249762 0,187,255
chr17 22252005 22252323 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 554 . 22252005 22252323 55,255,0
chr17 22252044 22252328 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 681 . 22252044 22252328 184,255,0
chr17 22252917 22253376 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 22252917 22253376 255,0,0
chr17 22252925 22253413 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 22252925 22253413 255,0,0
chr17 22254637 22255302 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 781 . 22254637 22255302 255,223,0
chr17 22254642 22255335 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 672 . 22254642 22255335 175,255,0
chr17 22258184 22258711 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 495 . 22258184 22258711 0,255,5
chr17 22258213 22258696 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 410 . 22258213 22258696 0,255,91
chr17 22259663 22260059 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 545 . 22259663 22260059 45,255,0
chr17 22259664 22260062 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 518 . 22259664 22260062 18,255,0
chr17 22260379 22261680 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 22260379 22261680 255,0,0
chr17 22260411 22261666 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 22260411 22261666 255,0,0
chr17 41381658 41382459 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 203 . 41381658 41382459 0,207,255
chr17 41381694 41382318 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 194 . 41381694 41382318 0,197,255
chr17 41399839 41401022 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 204 . 41399839 41401022 0,208,255
chr17 41399956 41401014 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 216 . 41399956 41401014 0,220,255
chr17 41466093 41466369 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 292 . 41466093 41466369 0,255,212
chr17 78717980 78718695 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 261 . 78717980 78718695 0,255,243
chr17 78718016 78718690 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 173 . 78718016 78718690 0,176,255
chr18 107879 109280 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 107879 109280 255,0,0
chr18 107893 109297 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 107893 109297 255,0,0
chr18 110145 110709 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 958 . 110145 110709 255,42,0
chr18 110206 110707 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 826 . 110206 110707 255,177,0
chr18 18511022 18511275 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 441 . 18511022 18511275 0,255,60
chr18 18511879 18512311 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 123 . 18511879 18512311 0,125,255
chr18 18512843 18513159 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 669 . 18512843 18513159 172,255,0
chr18 18515969 18516307 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 403 . 18515969 18516307 0,255,98
chr18 18516020 18516307 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 636 . 18516020 18516307 138,255,0
chr18 18516861 18517292 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 284 . 18516861 18517292 0,255,220
chr18 18516883 18517702 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 309 . 18516883 18517702 0,255,194
chr18 18518737 18520224 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 18518737 18520224 255,0,0
chr18 18518779 18520252 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 18518779 18520252 255,0,0
chr19 7515537 7515991 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 270 . 7515537 7515991 0,255,234
chr19 7515574 7515963 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 216 . 7515574 7515963 0,220,255
chr19 27731874 27733399 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 27731874 27733399 255,0,0
chr19 27731881 27732831 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 27731881 27732831 255,0,0
chr19 27733019 27733399 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 27733019 27733399 255,0,0
chr19 27733883 27734645 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 779 . 27733883 27734645 255,225,0
chr19 27733899 27734604 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 842 . 27733899 27734604 255,161,0
chr19 27736216 27736600 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 798 . 27736216 27736600 255,206,0
chr19 27736234 27736597 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 27736234 27736597 255,0,0
chr19 27738335 27738878 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 27738335 27738878 255,0,0
chr19 27738366 27738720 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 27738366 27738720 255,0,0
chr19 44915276 44915779 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 255 . 44915276 44915779 0,255,249
chr19 44915291 44915779 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 391 . 44915291 44915779 0,255,111
chr19_gl000208_random 49 392 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 371 . 49 392 0,255,131
chr19_gl000208_random 54 421 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 598 . 54 421 99,255,0
chr19_gl000208_random 89620 91879 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 644 . 89620 91879 146,255,0
chr19_gl000208_random 89649 90872 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 503 . 89649 90872 3,255,0
chr19_gl000208_random 91212 91851 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 509 . 91212 91851 9,255,0
chr19_gl000208_random 92115 92495 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 322 . 92115 92495 0,255,181
chr19_gl000208_random 92166 92477 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 237 . 92166 92477 0,241,255
chr2 740562 740803 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 140 . 740562 740803 0,142,255
chr2 87623768 87624021 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 218 . 87623768 87624021 0,222,255
chr2 87625492 87625754 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 141 . 87625492 87625754 0,143,255
chr2 87641766 87642194 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 403 . 87641766 87642194 0,255,98
chr2 87641838 87642185 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 214 . 87641838 87642185 0,218,255
chr2 90481653 90482444 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 388 . 90481653 90482444 0,255,114
chr2 90481693 90482419 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 440 . 90481693 90482419 0,255,61
chr2 91596791 91597567 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 92 . 91596791 91597567 0,93,255
chr2 91604743 91605052 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 187 . 91604743 91605052 0,190,255
chr2 92269107 92269737 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 92269107 92269737 255,0,0
chr2 92269107 92269770 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 92269107 92269770 255,0,0
chr2 92281230 92281499 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 306 . 92281230 92281499 0,255,197
chr2 92281230 92281523 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 227 . 92281230 92281523 0,231,255
chr2 92290486 92291666 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 92290486 92291666 255,0,0
chr2 92290516 92291643 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 92290516 92291643 255,0,0
chr2 92296077 92297656 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 92296077 92297656 255,0,0
chr2 92296083 92297643 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 92296083 92297643 255,0,0
chr2 92297811 92298148 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 591 . 92297811 92298148 92,255,0
chr2 92297839 92298152 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 525 . 92297839 92298152 25,255,0
chr2 92306670 92307898 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 92306670 92307898 255,0,0
chr2 92306688 92307558 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 92306688 92307558 255,0,0
chr2 92307734 92307975 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 78 . 92307734 92307975 0,79,255
chr2 92309494 92309793 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 556 . 92309494 92309793 57,255,0
chr2 92309518 92310283 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 423 . 92309518 92310283 0,255,78
chr2 92309991 92310263 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 406 . 92309991 92310263 0,255,95
chr2 92310517 92310810 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 268 . 92310517 92310810 0,255,236
chr2 92310525 92310790 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 410 . 92310525 92310790 0,255,91
chr2 92312683 92313499 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 458 . 92312683 92313499 0,255,42
chr2 92312764 92313502 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 377 . 92312764 92313502 0,255,125
chr2 92313759 92314003 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 393 . 92313759 92314003 0,255,109
chr2 92318052 92318504 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 398 . 92318052 92318504 0,255,104
chr2 92318084 92318421 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 292 . 92318084 92318421 0,255,212
chr2 92318704 92319433 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 460 . 92318704 92319433 0,255,40
chr2 92318708 92319428 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 570 . 92318708 92319428 71,255,0
chr2 92319854 92320689 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 593 . 92319854 92320689 94,255,0
chr2 92319884 92320733 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 600 . 92319884 92320733 102,255,0
chr2 92324271 92325968 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 92324271 92325968 255,0,0
chr2 92324328 92324659 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 676 . 92324328 92324659 179,255,0
chr2 92324824 92325943 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 92324824 92325943 255,0,0
chr2 109815890 109816242 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 222 . 109815890 109816242 0,226,255
chr2 162135711 162136927 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 160 . 162135711 162136927 0,163,255
chr2 162135720 162136087 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 69 . 162135720 162136087 0,70,255
chr2 162136366 162136744 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 119 . 162136366 162136744 0,121,255
chr2 162138049 162138366 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 120 . 162138049 162138366 0,122,255
chr2 162138731 162139032 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 148 . 162138731 162139032 0,150,255
chr2 216225699 216226172 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 165 . 216225699 216226172 0,168,255
chr2 216225768 216226123 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 149 . 216225768 216226123 0,151,255
chr20 4004643 4004956 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 96 . 4004643 4004956 0,97,255
chr20 4004691 4005069 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 167 . 4004691 4005069 0,170,255
chr20 29653204 29653686 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 128 . 29653204 29653686 0,130,255
chr20 46523542 46523930 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 139 . 46523542 46523930 0,141,255
chr20 46523587 46524184 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 100 . 46523587 46524184 0,102,255
chr20 47131804 47132590 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 313 . 47131804 47132590 0,255,190
chr20 47132041 47132400 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 113 . 47132041 47132400 0,115,255
chr20 62719980 62720273 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 203 . 62719980 62720273 0,207,255
chr20 62720002 62720244 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 172 . 62720002 62720244 0,175,255
chr21 9699456 9699880 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 171 . 9699456 9699880 0,174,255
chr21 9699497 9699931 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 133 . 9699497 9699931 0,135,255
chr21 9826949 9827426 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 876 . 9826949 9827426 255,126,0
chr21 9826950 9827492 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 852 . 9826950 9827492 255,150,0
chr21 10702132 10702666 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 297 . 10702132 10702666 0,255,207
chr21 10702132 10702840 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 308 . 10702132 10702840 0,255,195
chr21 11186438 11186866 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 11186438 11186866 255,0,0
chr21 11186467 11186831 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 11186467 11186831 255,0,0
chr22 18359655 18359934 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 84 . 18359655 18359934 0,85,255
chr22 18359660 18360002 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 80 . 18359660 18360002 0,81,255
chr22 18688072 18688547 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 723 . 18688072 18688547 227,255,0
chr22 18688087 18688504 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 748 . 18688087 18688504 252,255,0
chr22 18717855 18718294 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 18717855 18718294 255,0,0
chr22 18717880 18718281 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 18717880 18718281 255,0,0
chr22 18878018 18878317 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 333 . 18878018 18878317 0,255,170
chr22 18883660 18884149 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 18883660 18884149 255,0,0
chr22 18883680 18884125 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 18883680 18884125 255,0,0
chr22 20689338 20689803 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 598 . 20689338 20689803 99,255,0
chr22 20689366 20689792 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 447 . 20689366 20689792 0,255,54
chr22 51082087 51082450 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 209 . 51082087 51082450 0,213,255
chr22 51082137 51082521 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 185 . 51082137 51082521 0,188,255
chr3 75718171 75718647 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 821 . 75718171 75718647 255,182,0
chr3 75718179 75718621 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 544 . 75718179 75718621 44,255,0
chr4 1422275 1422884 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 122 . 1422275 1422884 0,124,255
chr4 7865688 7865984 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 182 . 7865688 7865984 0,185,255
chr4 9273923 9274219 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 80 . 9273923 9274219 0,81,255
chr4 40297286 40297633 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 156 . 40297286 40297633 0,159,255
chr4 49103507 49104320 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 225 . 49103507 49104320 0,229,255
chr4 49103585 49104595 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 192 . 49103585 49104595 0,195,255
chr4 49110526 49111585 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 142 . 49110526 49111585 0,144,255
chr4 49121972 49122405 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 341 . 49121972 49122405 0,255,162
chr4 49122026 49122370 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 609 . 49122026 49122370 111,255,0
chr4 49151350 49151689 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 172 . 49151350 49151689 0,175,255
chr4 49293855 49294394 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 157 . 49293855 49294394 0,160,255
chr4 49293874 49294234 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 95 . 49293874 49294234 0,96,255
chr4 49305755 49306050 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 98 . 49305755 49306050 0,99,255
chr4 49305771 49306051 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 207 . 49305771 49306051 0,211,255
chr4 49318231 49319175 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 657 . 49318231 49319175 160,255,0
chr4 49318747 49319083 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 663 . 49318747 49319083 166,255,0
chr4 49515603 49515894 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 99 . 49515603 49515894 0,100,255
chr4 49659544 49659787 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 175 . 49659544 49659787 0,178,255
chr4 68264581 68264966 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 471 . 68264581 68264966 0,255,29
chr4 68264643 68264946 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 581 . 68264643 68264946 82,255,0
chr4 68265223 68265969 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 68265223 68265969 255,0,0
chr4 68265346 68266040 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 68265346 68266040 255,0,0
chr4 69241971 69242264 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 193 . 69241971 69242264 0,196,255
chr4 69242054 69242295 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 171 . 69242054 69242295 0,174,255
chr4 190154943 190155335 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 591 . 190154943 190155335 92,255,0
chr4 190154991 190155270 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 409 . 190154991 190155270 0,255,92
chr4 190156149 190156500 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 271 . 190156149 190156500 0,255,233
chr4 190156212 190156453 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 116 . 190156212 190156453 0,118,255
chr4 190802370 190802693 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 357 . 190802370 190802693 0,255,145
chr4 190802397 190802690 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 283 . 190802397 190802690 0,255,221
chr4 190943308 190943741 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 118 . 190943308 190943741 0,120,255
chr4 190943379 190943741 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 158 . 190943379 190943741 0,161,255
chr4 191043922 191044289 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 311 . 191043922 191044289 0,255,192
chr5 10061 11730 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 10061 11730 255,0,0
chr5 10063 11744 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 10063 11744 255,0,0
chr5 17353962 17354378 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 104 . 17353962 17354378 0,106,255
chr5 17354070 17354483 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 162 . 17354070 17354483 0,165,255
chr5 17585228 17585609 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 129 . 17585228 17585609 0,131,255
chr5 17598904 17599415 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 137 . 17598904 17599415 0,139,255
chr5 17598921 17599317 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 194 . 17598921 17599317 0,197,255
chr5 49410104 49410447 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 402 . 49410104 49410447 0,255,99
chr5 49410117 49410402 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 405 . 49410117 49410402 0,255,96
chr5 49437200 49437495 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 326 . 49437200 49437495 0,255,177
chr5 49437217 49437473 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 351 . 49437217 49437473 0,255,151
chr5 49440524 49441072 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 713 . 49440524 49441072 217,255,0
chr5 49440604 49441044 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 717 . 49440604 49441044 221,255,0
chr5 178012447 178012744 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 216 . 178012447 178012744 0,220,255
chr6 371718 372137 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 159 . 371718 372137 0,162,255
chr6 371834 372221 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 133 . 371834 372221 0,135,255
chr6 58776317 58779464 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 945 . 58776317 58779464 255,56,0
chr6 58776332 58779482 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 58776332 58779482 255,0,0
chr6 83274419 83274726 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 134 . 83274419 83274726 0,136,255
chr6 157731569 157732015 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 573 . 157731569 157732015 74,255,0
chr6 157731570 157732034 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 498 . 157731570 157732034 0,255,2
chr7 24082 24463 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 267 . 24082 24463 0,255,237
chr7 1311933 1312269 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 106 . 1311933 1312269 0,108,255
chr7 56438351 56438680 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 165 . 56438351 56438680 0,168,255
chr7 56438872 56439636 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 390 . 56438872 56439636 0,255,112
chr7 56438893 56439696 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 335 . 56438893 56439696 0,255,168
chr7 56440155 56440605 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 102 . 56440155 56440605 0,104,255
chr7 56440168 56440572 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 218 . 56440168 56440572 0,222,255
chr7 61083528 61083863 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 222 . 61083528 61083863 0,226,255
chr7 61083543 61083831 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 133 . 61083543 61083831 0,135,255
chr7 61243062 61243367 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 188 . 61243062 61243367 0,191,255
chr7 61968555 61969864 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 61968555 61969864 255,0,0
chr7 61968598 61969874 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 61968598 61969874 255,0,0
chr7 61970115 61970606 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 61970115 61970606 255,0,0
chr7 61970175 61970592 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 61970175 61970592 255,0,0
chr7 61975359 61975675 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 512 . 61975359 61975675 12,255,0
chr7 61975385 61975639 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 285 . 61975385 61975639 0,255,219
chr7 157253993 157254262 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 238 . 157253993 157254262 0,242,255
chr8 43793700 43794168 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 43793700 43794168 255,0,0
chr8 43793750 43794166 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 43793750 43794166 255,0,0
chr8 43820950 43821268 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 528 . 43820950 43821268 28,255,0
chr8 43820957 43821252 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 835 . 43820957 43821252 255,168,0
chr8 43822363 43822620 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 422 . 43822363 43822620 0,255,79
chr8 43824614 43824957 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 524 . 43824614 43824957 24,255,0
chr8 43824634 43824922 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 447 . 43824634 43824922 0,255,54
chr8 43826831 43827345 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 496 . 43826831 43827345 0,255,4
chr8 43826885 43827364 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 359 . 43826885 43827364 0,255,143
chr8 43827924 43828248 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 984 . 43827924 43828248 255,16,0
chr8 43827926 43828275 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 575 . 43827926 43828275 76,255,0
chr8 43831021 43831346 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 640 . 43831021 43831346 142,255,0
chr8 43831026 43831446 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 526 . 43831026 43831446 26,255,0
chr8 43835329 43835572 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 367 . 43835329 43835572 0,255,135
chr8 43837131 43837664 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 43837131 43837664 255,0,0
chr8 43837131 43837688 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 945 . 43837131 43837688 255,56,0
chr8 43838439 43838733 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 344 . 43838439 43838733 0,255,159
chr8 43838455 43838748 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 709 . 43838455 43838748 213,255,0
chr8 46841386 46841835 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 571 . 46841386 46841835 72,255,0
chr8 46841516 46841843 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 622 . 46841516 46841843 124,255,0
chr8 46842354 46842642 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 411 . 46842354 46842642 0,255,90
chr8 46842359 46842686 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 330 . 46842359 46842686 0,255,173
chr8 46844084 46844535 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 46844084 46844535 255,0,0
chr8 46844087 46844473 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 46844087 46844473 255,0,0
chr8 46844760 46845006 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 388 . 46844760 46845006 0,255,114
chr8 46848280 46848697 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 735 . 46848280 46848697 239,255,0
chr8 46848284 46848693 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 965 . 46848284 46848693 255,35,0
chr8 46849027 46850442 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 46849027 46850442 255,0,0
chr8 46849048 46850438 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 46849048 46850438 255,0,0
chr8 46854121 46854374 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 427 . 46854121 46854374 0,255,74
chr8 46855293 46855826 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 374 . 46855293 46855826 0,255,128
chr8 46855330 46855717 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 205 . 46855330 46855717 0,209,255
chr8 86785930 86786290 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 128 . 86785930 86786290 0,130,255
chr8 86823364 86823609 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 114 . 86823364 86823609 0,116,255
chr8 144751591 144751884 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 196 . 144751591 144751884 0,199,255
chr9 44992494 44993040 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 193 . 44992494 44993040 0,196,255
chr9 44992713 44993047 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 136 . 44992713 44993047 0,138,255
chr9 66833640 66833988 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 359 . 66833640 66833988 0,255,143
chr9 66970946 66971539 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 66970946 66971539 255,0,0
chr9 66970972 66971516 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 66970972 66971516 255,0,0
chr9 67320344 67321017 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 67320344 67321017 255,0,0
chr9 67320375 67320977 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 67320375 67320977 255,0,0
chr9 67791260 67791729 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 148 . 67791260 67791729 0,150,255
chr9 67791410 67791716 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 152 . 67791410 67791716 0,155,255
chr9 69710752 69711354 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 69710752 69711354 255,0,0
chr9 69710774 69711311 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 69710774 69711311 255,0,0
chr9 135894787 135895275 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 209 . 135894787 135895275 0,213,255
chr9 135894894 135895376 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 143 . 135894894 135895376 0,145,255
chr9 140222591 140222930 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 272 . 140222591 140222930 0,255,232
chr9 141122264 141122775 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 105 . 141122264 141122775 0,107,255
chr9 141122408 141122649 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 100 . 141122408 141122649 0,102,255
chr9_gl000199_random 34258 34706 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 34258 34706 255,0,0
chr9_gl000199_random 34278 34683 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 34278 34683 255,0,0
chr9_gl000199_random 40100 40580 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 876 . 40100 40580 255,126,0
chr9_gl000199_random 40105 40588 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 40105 40588 255,0,0
chr9_gl000199_random 44128 45159 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 638 . 44128 45159 140,255,0
chr9_gl000199_random 44170 44497 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 475 . 44170 44497 0,255,25
chr9_gl000199_random 44655 45136 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 502 . 44655 45136 2,255,0
chr9_gl000199_random 46238 46507 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 478 . 46238 46507 0,255,22
chr9_gl000199_random 49617 50027 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 534 . 49617 50027 34,255,0
chr9_gl000199_random 49689 50008 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 485 . 49689 50008 0,255,15
chr9_gl000199_random 51153 51611 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 227 . 51153 51611 0,231,255
chr9_gl000199_random 51907 52244 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 283 . 51907 52244 0,255,221
chr9_gl000199_random 52015 52257 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 203 . 52015 52257 0,207,255
chr9_gl000199_random 54732 55037 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 319 . 54732 55037 0,255,184
chr9_gl000199_random 55518 55948 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 678 . 55518 55948 181,255,0
chr9_gl000199_random 55526 55928 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 334 . 55526 55928 0,255,169
chr9_gl000199_random 56880 57400 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 684 . 56880 57400 187,255,0
chr9_gl000199_random 57037 57385 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 658 . 57037 57385 161,255,0
chr9_gl000199_random 60682 60995 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 504 . 60682 60995 4,255,0
chr9_gl000199_random 60714 61017 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 274 . 60714 61017 0,255,230
chr9_gl000199_random 61338 61662 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 130 . 61338 61662 0,132,255
chr9_gl000199_random 63508 63846 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 86 . 63508 63846 0,87,255
chr9_gl000199_random 63572 63884 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 160 . 63572 63884 0,163,255
chr9_gl000199_random 65475 65840 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 227 . 65475 65840 0,231,255
chr9_gl000199_random 65491 65838 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 225 . 65491 65838 0,229,255
chr9_gl000199_random 66813 67374 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 541 . 66813 67374 41,255,0
chr9_gl000199_random 66825 67367 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 414 . 66825 67367 0,255,87
chr9_gl000199_random 72384 73166 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 72384 73166 255,0,0
chr9_gl000199_random 72423 73207 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 72423 73207 255,0,0
chr9_gl000199_random 77039 77461 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 274 . 77039 77461 0,255,230
chr9_gl000199_random 77106 77362 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 192 . 77106 77362 0,195,255
chr9_gl000199_random 78928 79484 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 431 . 78928 79484 0,255,70
chr9_gl000199_random 78952 79474 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 428 . 78952 79474 0,255,73
chr9_gl000199_random 82854 83276 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 933 . 82854 83276 255,68,0
chr9_gl000199_random 82873 83244 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 639 . 82873 83244 141,255,0
chr9_gl000199_random 84195 84654 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 842 . 84195 84654 255,161,0
chr9_gl000199_random 84200 84580 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 836 . 84200 84580 255,167,0
chr9_gl000199_random 86273 86537 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 493 . 86273 86537 0,255,7
chr9_gl000199_random 91426 92973 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 900 . 91426 92973 255,102,0
chr9_gl000199_random 91443 92946 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 861 . 91443 92946 255,141,0
chr9_gl000199_random 101565 101888 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 317 . 101565 101888 0,255,186
chr9_gl000199_random 106112 106459 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 175 . 106112 106459 0,178,255
chr9_gl000199_random 106155 106468 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 234 . 106155 106468 0,238,255
chr9_gl000199_random 106893 107490 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 106893 107490 255,0,0
chr9_gl000199_random 106903 107475 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 106903 107475 255,0,0
chr9_gl000199_random 107890 108306 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 256 . 107890 108306 0,255,248
chr9_gl000199_random 108925 109201 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 529 . 108925 109201 29,255,0
chr9_gl000199_random 114300 114794 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 571 . 114300 114794 72,255,0
chr9_gl000199_random 114310 114832 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 573 . 114310 114832 74,255,0
chr9_gl000199_random 116108 116465 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 265 . 116108 116465 0,255,239
chr9_gl000199_random 116121 116469 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 318 . 116121 116469 0,255,185
chr9_gl000199_random 118496 119059 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 390 . 118496 119059 0,255,112
chr9_gl000199_random 118506 119058 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 500 . 118506 119058 0,255,0
chr9_gl000199_random 120281 120618 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 200 . 120281 120618 0,204,255
chr9_gl000199_random 122330 122608 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 557 . 122330 122608 58,255,0
chr9_gl000199_random 124347 124950 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 906 . 124347 124950 255,95,0
chr9_gl000199_random 124373 124971 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 589 . 124373 124971 90,255,0
chr9_gl000199_random 129632 129935 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 367 . 129632 129935 0,255,135
chr9_gl000199_random 129634 129925 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 509 . 129634 129925 9,255,0
chr9_gl000199_random 134177 135310 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 702 . 134177 135310 206,255,0
chr9_gl000199_random 134200 135272 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 683 . 134200 135272 186,255,0
chr9_gl000199_random 136788 137315 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 283 . 136788 137315 0,255,221
chr9_gl000199_random 136827 137319 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 350 . 136827 137319 0,255,153
chr9_gl000199_random 140421 140794 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 435 . 140421 140794 0,255,66
chr9_gl000199_random 140425 140793 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 440 . 140425 140793 0,255,61
chr9_gl000199_random 141134 141661 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 662 . 141134 141661 165,255,0
chr9_gl000199_random 141184 141672 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 498 . 141184 141672 0,255,2
chr9_gl000199_random 145295 145610 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 108 . 145295 145610 0,110,255
chr9_gl000199_random 146412 147351 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 445 . 146412 147351 0,255,56
chr9_gl000199_random 146471 147399 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 524 . 146471 147399 24,255,0
chr9_gl000199_random 152478 152841 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 175 . 152478 152841 0,178,255
chr9_gl000199_random 154202 154857 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 318 . 154202 154857 0,255,185
chr9_gl000199_random 154571 154854 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 626 . 154571 154854 128,255,0
chr9_gl000199_random 155795 156606 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 667 . 155795 156606 170,255,0
chr9_gl000199_random 155807 156602 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 645 . 155807 156602 147,255,0
chr9_gl000199_random 165551 165891 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 324 . 165551 165891 0,255,179
chr9_gl000199_random 165566 165864 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 399 . 165566 165864 0,255,103
chr9_gl000199_random 167998 168744 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 167998 168744 255,0,0
chr9_gl000199_random 168040 168711 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 168040 168711 255,0,0
chrM 15835 16221 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 161 . 15835 16221 0,164,255
chrM 15881 16139 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 92 . 15881 16139 0,93,255
chrUn_gl000212 40496 41301 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 40496 41301 255,0,0
chrUn_gl000212 40512 41294 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 40512 41294 255,0,0
chrUn_gl000214 64302 65305 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 64302 65305 255,0,0
chrUn_gl000214 64333 65278 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 64333 65278 255,0,0
chrUn_gl000214 118133 118633 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 156 . 118133 118633 0,159,255
chrUn_gl000216 138013 138318 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 543 . 138013 138318 43,255,0
chrUn_gl000216 145044 145530 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 145044 145530 255,0,0
chrUn_gl000216 145069 145506 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 145069 145506 255,0,0
chrUn_gl000216 155125 155371 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 334 . 155125 155371 0,255,169
chrUn_gl000216 162230 162655 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 406 . 162230 162655 0,255,95
chrUn_gl000216 162292 162636 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 698 . 162292 162636 201,255,0
chrUn_gl000216 164217 164573 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 571 . 164217 164573 72,255,0
chrUn_gl000216 164268 164567 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 698 . 164268 164567 201,255,0
chrUn_gl000216 169407 169773 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 420 . 169407 169773 0,255,81
chrUn_gl000216 169432 169736 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 573 . 169432 169736 74,255,0
chrUn_gl000220 101698 102060 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 328 . 101698 102060 0,255,175
chrUn_gl000220 101721 102060 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 218 . 101721 102060 0,222,255
chrUn_gl000220 102218 102961 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 357 . 102218 102961 0,255,145
chrUn_gl000220 102230 102956 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 180 . 102230 102956 0,183,255
chrUn_gl000220 103274 103781 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 97 . 103274 103781 0,98,255
chrUn_gl000220 105065 105453 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 179 . 105065 105453 0,182,255
chrUn_gl000220 105092 105409 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 161 . 105092 105409 0,164,255
chrUn_gl000220 106688 106939 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 150 . 106688 106939 0,153,255
chrUn_gl000220 109282 110783 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 417 . 109282 110783 0,255,84
chrUn_gl000220 109327 110793 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 247 . 109327 110793 0,251,255
chrUn_gl000220 113451 113697 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 146 . 113451 113697 0,148,255
chrUn_gl000220 114756 115283 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 154 . 114756 115283 0,157,255
chrUn_gl000220 114799 115281 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 214 . 114799 115281 0,218,255
chrUn_gl000220 115761 116103 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 233 . 115761 116103 0,237,255
chrUn_gl000220 115794 116112 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 235 . 115794 116112 0,239,255
chrUn_gl000220 117640 117981 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 246 . 117640 117981 0,250,255
chrUn_gl000220 153277 154781 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 452 . 153277 154781 0,255,48
chrUn_gl000220 153288 154776 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 294 . 153288 154776 0,255,210
chrUn_gl000220 157371 157693 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 249 . 157371 157693 0,253,255
chrUn_gl000220 158680 159305 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 467 . 158680 159305 0,255,33
chrUn_gl000220 158693 159327 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 271 . 158693 159327 0,255,233
chrUn_gl000220 159641 160153 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 582 . 159641 160153 83,255,0
chrUn_gl000220 159661 160150 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 535 . 159661 160150 35,255,0
chrUn_gl000220 161003 161568 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 254 . 161003 161568 0,255,250
chrUn_gl000220 161005 161566 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 254 . 161005 161566 0,255,250
chrUn_gl000222 84096 84664 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 84096 84664 255,0,0
chrUn_gl000222 84111 84648 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 84111 84648 255,0,0
chrUn_gl000224 3723 4650 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 154 . 3723 4650 0,157,255
chrUn_gl000224 3863 4663 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 222 . 3863 4663 0,226,255
chrUn_gl000224 5365 5672 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 98 . 5365 5672 0,99,255
chrUn_gl000224 11901 12286 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 251 . 11901 12286 0,255,253
chrUn_gl000224 11930 12247 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 198 . 11930 12247 0,201,255
chrUn_gl000224 17864 19164 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 477 . 17864 19164 0,255,23
chrUn_gl000224 17940 19155 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 406 . 17940 19155 0,255,95
chrUn_gl000225 6700 7019 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 361 . 6700 7019 0,255,141
chrUn_gl000225 6716 7010 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 567 . 6716 7010 68,255,0
chrUn_gl000225 13666 14074 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 177 . 13666 14074 0,180,255
chrUn_gl000225 13748 14063 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 190 . 13748 14063 0,193,255
chrUn_gl000225 17006 17295 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 328 . 17006 17295 0,255,175
chrUn_gl000225 25455 25861 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 684 . 25455 25861 187,255,0
chrUn_gl000225 25492 25817 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 25492 25817 255,0,0
chrUn_gl000225 50769 51053 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 589 . 50769 51053 90,255,0
chrUn_gl000225 56042 56331 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 379 . 56042 56331 0,255,123
chrUn_gl000225 57032 57326 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 128 . 57032 57326 0,130,255
chrUn_gl000225 62295 62594 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 188 . 62295 62594 0,191,255
chrUn_gl000225 67311 67628 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 479 . 67311 67628 0,255,21
chrUn_gl000225 67317 67629 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 647 . 67317 67629 149,255,0
chrUn_gl000225 70462 71282 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 940 . 70462 71282 255,61,0
chrUn_gl000225 70500 71255 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 461 . 70500 71255 0,255,39
chrUn_gl000225 85526 85786 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 265 . 85526 85786 0,255,239
chrUn_gl000225 92412 92852 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 175 . 92412 92852 0,178,255
chrUn_gl000225 92582 92852 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 217 . 92582 92852 0,221,255
chrUn_gl000225 99130 99573 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 857 . 99130 99573 255,145,0
chrUn_gl000225 99167 99537 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 99167 99537 255,0,0
chrUn_gl000225 110263 110519 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 373 . 110263 110519 0,255,129
chrUn_gl000225 111429 111761 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 522 . 111429 111761 22,255,0
chrUn_gl000225 111455 111762 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 253 . 111455 111762 0,255,251
chrUn_gl000225 112349 112927 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 334 . 112349 112927 0,255,169
chrUn_gl000225 112352 112998 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 227 . 112352 112998 0,231,255
chrUn_gl000225 125618 126015 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 280 . 125618 126015 0,255,224
chrUn_gl000225 125630 126024 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 218 . 125630 126024 0,222,255
chrUn_gl000225 130276 130733 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 391 . 130276 130733 0,255,111
chrUn_gl000225 130364 130657 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 291 . 130364 130657 0,255,213
chrUn_gl000225 131561 131917 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 372 . 131561 131917 0,255,130
chrUn_gl000225 131598 131857 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 268 . 131598 131857 0,255,236
chrUn_gl000225 133583 133955 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 379 . 133583 133955 0,255,123
chrUn_gl000225 133594 133927 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 488 . 133594 133927 0,255,12
chrUn_gl000225 134784 135052 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 346 . 134784 135052 0,255,157
chrUn_gl000226 927 1284 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 370 . 927 1284 0,255,132
chrUn_gl000226 962 1255 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 609 . 962 1255 111,255,0
chrUn_gl000226 1479 1860 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 548 . 1479 1860 48,255,0
chrUn_gl000226 1486 1898 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 539 . 1486 1898 39,255,0
chrUn_gl000226 3139 3466 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 490 . 3139 3466 0,255,10
chrUn_gl000226 3144 3473 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 438 . 3144 3473 0,255,63
chrUn_gl000226 4168 4515 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 296 . 4168 4515 0,255,208
chrUn_gl000226 4196 4508 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 305 . 4196 4508 0,255,198
chrUn_gl000226 5019 5496 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 407 . 5019 5496 0,255,94
chrUn_gl000226 5025 5505 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 531 . 5025 5505 31,255,0
chrUn_gl000226 5738 6132 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 248 . 5738 6132 0,252,255
chrUn_gl000226 5757 6041 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 238 . 5757 6041 0,242,255
chrUn_gl000226 6573 7540 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 549 . 6573 7540 49,255,0
chrUn_gl000226 6576 7548 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 432 . 6576 7548 0,255,69
chrUn_gl000226 9987 10279 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 252 . 9987 10279 0,255,252
chrUn_gl000226 12314 12725 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 577 . 12314 12725 78,255,0
chrUn_gl000226 12425 12728 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 577 . 12425 12728 78,255,0
chrUn_gl000226 13241 13549 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 122 . 13241 13549 0,124,255
chrUn_gl000226 13708 14911 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 13708 14911 255,0,0
chrUn_gl000226 13763 14084 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 634 . 13763 14084 136,255,0
chrUn_gl000226 14255 14912 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 14255 14912 255,0,0
chrUn_gl000228 27178 27686 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 459 . 27178 27686 0,255,41
chrUn_gl000228 27203 27715 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 516 . 27203 27715 16,255,0
chrUn_gl000228 116344 116717 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 228 . 116344 116717 0,232,255
chrUn_gl000228 117047 117828 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 117047 117828 255,0,0
chrUn_gl000228 117049 117804 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 117049 117804 255,0,0
chrUn_gl000228 118076 118873 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 118076 118873 255,0,0
chrUn_gl000228 118077 118884 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 118077 118884 255,0,0
chrUn_gl000235 256 575 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 411 . 256 575 0,255,90
chrUn_gl000235 277 693 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 350 . 277 693 0,255,153
chrUn_gl000243 20904 21354 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 217 . 20904 21354 0,221,255
chrUn_gl000243 20909 21365 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 290 . 20909 21365 0,255,214
chrX 58568239 58569845 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 530 . 58568239 58569845 30,255,0
chrX 58568269 58569163 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 485 . 58568269 58569163 0,255,15
chrX 58569322 58569928 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 398 . 58569322 58569928 0,255,104
chrX 58572580 58573973 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 497 . 58572580 58573973 0,255,3
chrX 58572777 58573283 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 404 . 58572777 58573283 0,255,97
chrX 58573436 58574011 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 282 . 58573436 58574011 0,255,222
chrX 58578551 58580269 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 864 . 58578551 58580269 255,138,0
chrX 58578745 58580263 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 779 . 58578745 58580263 255,225,0
chrX 61682924 61683409 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 259 . 61682924 61683409 0,255,245
chrX 61683028 61683383 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 105 . 61683028 61683383 0,107,255
chrX 61686564 61686846 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 647 . 61686564 61686846 149,255,0
chrX 61687236 61687574 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 747 . 61687236 61687574 251,255,0
chrX 61687252 61687577 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 61687252 61687577 255,0,0
chrX 61691373 61692177 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 61691373 61692177 255,0,0
chrX 61691427 61692130 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 61691427 61692130 255,0,0
chrX 61698980 61699529 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 419 . 61698980 61699529 0,255,82
chrX 61699116 61699477 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 237 . 61699116 61699477 0,241,255
chrX 61700491 61700818 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 753 . 61700491 61700818 255,251,0
chrX 61700503 61700844 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 372 . 61700503 61700844 0,255,130
chrX 61710532 61711444 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 746 . 61710532 61711444 250,255,0
chrX 61710575 61710858 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 523 . 61710575 61710858 23,255,0
chrX 61711125 61711448 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 718 . 61711125 61711448 222,255,0
chrX 61712387 61712692 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 278 . 61712387 61712692 0,255,226
chrX 61712446 61712743 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 469 . 61712446 61712743 0,255,31
chrX 61718612 61719132 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 553 . 61718612 61719132 54,255,0
chrX 61718613 61719097 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 554 . 61718613 61719097 55,255,0
chrX 61719383 61719854 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 601 . 61719383 61719854 103,255,0
chrX 61719389 61719895 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 370 . 61719389 61719895 0,255,132
chrX 61730928 61731237 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 177 . 61730928 61731237 0,180,255
chrX 61730938 61731277 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 242 . 61730938 61731277 0,246,255
chrX 115004825 115005285 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 164 . 115004825 115005285 0,167,255
chrX 115004956 115005255 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 145 . 115004956 115005255 0,147,255
chrX 155259959 155260461 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 155259959 155260461 255,0,0
chrX 155259995 155260409 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 155259995 155260409 255,0,0
chrY 135005 135329 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 207 . 135005 135329 0,211,255
chrY 13129944 13130229 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 100 . 13129944 13130229 0,102,255
chrY 13460901 13461292 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 534 . 13460901 13461292 34,255,0
chrY 13460927 13461316 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 567 . 13460927 13461316 68,255,0
chrY 13467980 13468549 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 735 . 13467980 13468549 239,255,0
chrY 13468022 13468421 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 760 . 13468022 13468421 255,244,0
chrY 13474250 13474716 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 829 . 13474250 13474716 255,174,0
chrY 13474274 13474744 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 808 . 13474274 13474744 255,195,0
chrY 13480117 13480484 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 419 . 13480117 13480484 0,255,82
chrY 13480176 13480471 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 457 . 13480176 13480471 0,255,43
chrY 13485454 13485761 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 310 . 13485454 13485761 0,255,193
chrY 13485514 13485772 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 324 . 13485514 13485772 0,255,179
chrY 13489045 13489294 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 162 . 13489045 13489294 0,165,255
chrY 13689746 13690130 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 183 . 13689746 13690130 0,186,255
chrY 13689758 13690108 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 144 . 13689758 13690108 0,146,255
chrY 13694789 13695199 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 310 . 13694789 13695199 0,255,193
chrY 13694797 13695163 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 366 . 13694797 13695163 0,255,136
chrY 13707415 13707656 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 219 . 13707415 13707656 0,223,255
chrY 13719078 13719567 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 298 . 13719078 13719567 0,255,206
chrY 13719082 13719543 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 197 . 13719082 13719543 0,200,255
chrY 13842521 13842847 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 321 . 13842521 13842847 0,255,182
chrY 13842601 13842858 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 257 . 13842601 13842858 0,255,247
chrY 28796893 28797134 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 161 . 28796893 28797134 0,164,255
chrY 28817029 28817346 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 130 . 28817029 28817346 0,132,255
chrY 28817108 28817618 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 116 . 28817108 28817618 0,118,255
chrY 58820746 58821195 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 520 . 58820746 58821195 20,255,0
chrY 58820750 58821188 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 612 . 58820750 58821188 114,255,0
chrY 58822037 58822570 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 58822037 58822570 255,0,0
chrY 58822066 58822554 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 58822066 58822554 255,0,0
chrY 58823457 58823725 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 512 . 58823457 58823725 12,255,0
chrY 58825373 58825625 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 305 . 58825373 58825625 0,255,198
chrY 58827168 58827577 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 58827168 58827577 255,0,0
chrY 58827206 58827554 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 875 . 58827206 58827554 255,127,0
chrY 58831821 58832331 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 446 . 58831821 58832331 0,255,55
chrY 58831855 58832310 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 317 . 58831855 58832310 0,255,186
chrY 58834564 58835191 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 58834564 58835191 255,0,0
chrY 58834586 58835257 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 58834586 58835257 255,0,0
chrY 58835609 58835920 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 128 . 58835609 58835920 0,130,255
chrY 58835649 58835973 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 153 . 58835649 58835973 0,156,255
chrY 58844639 58845087 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 943 . 58844639 58845087 255,58,0
chrY 58844663 58845075 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 58844663 58845075 255,0,0
chrY 58846676 58847088 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 750 . 58846676 58847088 255,255,0
chrY 58846684 58847098 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 747 . 58846684 58847098 251,255,0
chrY 58853773 58854233 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 695 . 58853773 58854233 198,255,0
chrY 58853787 58854258 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 673 . 58853787 58854258 176,255,0
chrY 58858153 58858766 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 84 . 58858153 58858766 0,85,255
chrY 58858311 58858698 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 105 . 58858311 58858698 0,107,255
chrY 58860002 58860285 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 335 . 58860002 58860285 0,255,168
chrY 58865435 58866190 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 295 . 58865435 58866190 0,255,209
chrY 58865716 58866136 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 193 . 58865716 58866136 0,196,255
chrY 58869402 58869652 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 145 . 58869402 58869652 0,147,255
chrY 58871225 58871555 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 179 . 58871225 58871555 0,182,255
chrY 58871232 58871614 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 243 . 58871232 58871614 0,247,255
chrY 58873466 58873766 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 152 . 58873466 58873766 0,155,255
chrY 58875018 58875665 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 745 . 58875018 58875665 249,255,0
chrY 58875049 58875604 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 702 . 58875049 58875604 206,255,0
chrY 58882783 58883470 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 187 . 58882783 58883470 0,190,255
chrY 58882786 58883368 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 156 . 58882786 58883368 0,159,255
chrY 58885441 58885837 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 158 . 58885441 58885837 0,161,255
chrY 58888007 58889051 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 58888007 58889051 255,0,0
chrY 58888042 58888810 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 58888042 58888810 255,0,0
chrY 58892462 58892880 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 459 . 58892462 58892880 0,255,41
chrY 58892489 58892973 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 453 . 58892489 58892973 0,255,47
chrY 58894295 58894601 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 228 . 58894295 58894601 0,232,255
chrY 58900544 58901079 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 854 . 58900544 58901079 255,148,0
chrY 58900545 58900954 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 942 . 58900545 58900954 255,59,0
chrY 58902818 58903150 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 269 . 58902818 58903150 0,255,235
chrY 58902830 58903131 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 313 . 58902830 58903131 0,255,190
chrY 58904920 58905351 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 262 . 58904920 58905351 0,255,242
chrY 58904927 58905369 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 396 . 58904927 58905369 0,255,106
chrY 58907939 58908561 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 168 . 58907939 58908561 0,171,255
chrY 58910241 58910583 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 483 . 58910241 58910583 0,255,17
chrY 58910246 58910553 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 527 . 58910246 58910553 27,255,0
chrY 58912289 58912758 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 608 . 58912289 58912758 110,255,0
chrY 58912319 58912768 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 651 . 58912319 58912768 154,255,0
chrY 58914582 58914987 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 212 . 58914582 58914987 0,216,255
chrY 58914671 58914957 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 240 . 58914671 58914957 0,244,255
chrY 58915439 58915754 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 286 . 58915439 58915754 0,255,218
chrY 58915474 58915796 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 215 . 58915474 58915796 0,219,255
chrY 59362947 59363449 ID=SRX4637894;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374641:%20HDF-loading-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=mechanic%20loading; 1000 . 59362947 59363449 255,0,0
chrY 59363000 59363408 ID=SRX4637892;Name=ELK1%20(@%20Dermal%20fibroblast);Title=GSM3374639:%20HDF-control-IP%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Primary%20human%20dermal%20fibroblast;tissue=human%20dermal%20skin;passages=5;chip-antibody=Anti-ELK1%20antibody[E277]%20(abcam,ab32106);condition=control; 1000 . 59363000 59363408 255,0,0